Effects of fluoxetine and imipramine in rat fetuses treated during a critical gestational period: A macro and microscopic study

Revista Brasileira de Psiquiatria

Volumn 32, Issue 2, 2010, Pages 152-158

  Swerts, Cátia Aline Silva ^a   Costa, Ana Maria Duarte Dias ^a   Esteves, Alessandra ^b   Borato, Carla Elaine Silva ^a   Swerts, Mário Sérgio Oliveira ^a  

^a Universidade Jose do Rosario Vellano   (Brazil)

^b FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

Author keywords

Antidepressants; Fluoxetine; Imipramine; Pregnancy; Teratogens

Indexed keywords

FLUOXETINE; IMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN WEIGHT; CELL COUNT; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; FETUS; FETUS MALFORMATION; FETUS WEIGHT; FRONTAL LOBE; GESTATION PERIOD; HISTOPATHOLOGY; NONHUMAN; PLACENTA WEIGHT; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DOPAMINE UPTAKE INHIBITORS; FEMALE; FETAL WEIGHT; FETUS; FLUOXETINE; IMIPRAMINE; PLACENTA; PREGNANCY; RATS; RATS, WISTAR;

EID: 77958465446     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462009005000015     Document Type: Article

References (41)

1. Camacho RS, Cantinelli FS, Ribeiro CS, Cantilino A, Gonsales BK, Braguittoni E, Rennó Jr. R. Psychiatry disorders in pregnancy and puerperium: classification, diagnosis and treatment. Rev Psiquiatr Clín. 2006;33(2):92-102.
2. Osorio-de-Castro CG, Pepe VL, Luiza VL, Cosendey MA, Freitas AM, Miranda FF, Bermudez JA, Leal MdoC. Prescribed and reported drug use during pregnancy. Cad Saude Publica. 2004;20(Suppl1):S73-82.
3. Marcus SM, Flynn HA. Depression, antidepressant medication, and functioning outcomes among pregnant women. Int J Gynaecol Obstet. 2008;100(3):248-51.
4. Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clin Obstet Gynecol. 2008;51(1):106-18.
5. Dias VG, Aguni JS, Bezzon AK. Síndrome de Lyell por imipramina: relato de caso. Arq Bras Oftalmol. 2004;67(6):943-5.
6. Czeizel AE, Puhó EH, Acs N, Bánhidy F. Use of specified critical periods of different congenital abnormalities instead of the first trimester concept. Birth Defects Res A Clin Mol Teratol. 2008;82(3):139-46. (Pubitemid 351458135)
7. Zienowicz M, Wisłowska-Stanek A, Lehner M, Taracha E, Maciejak P, Sobolewska A, Szyndler J, Turzyńska D, Walkowiak J, Płaźnik A. Fluoxetine-induced anxiety and nervousness. Pharmacol Rep. 2006;58(1):115-9.
8. Basgül A, Akici A, Uzuner A, Kalaça S, Kavak ZN, Tural A, Oktay S. Drug utilization and teratogenicity risk categories during pregnancy. Adv Ther. 2007;24(1):68-80. (Pubitemid 46700867)
9. da-Silva VA, Altenburg SP, Malheiros LR, Thomaz TG, Lindsey CJ. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Braz J Med Biol Res. 1999;32(1):93-8.
10. Esteves A, Prada IL, Carvalho AF. Comparison of the neuron body number of areas brain cortex of dogs. Braz J Vet Res Anim Sci. 2004;41(5):332-8.
11. Avrushchenko MSH. Morphometric study of the Purkinje cells of the canine cerebellar cortex. Biull Eksp Biol Med. 1981;92(9):363-6.
12. Michon JJ, Li ZL, Shioura N, Anderson RJ, Tso MO. A comparative study of methods of photoreceptor morphometry. Invest Ophthalmol Vis Sci. 1991;32(2):280-4.
13. Rabinowicz T, Petetot JM, Gartside PS, Sheyn D, Sheyn T, de CM. Structure of the cerebral cortex in men and women. J Neuropathol Exp Neurol. 2002;61(1):46-57. (Pubitemid 34030566)
14. Zar JH. Biostatical analysis. 2nd ed. Prentice-Hall: Englewood Cliffs; 1984.
15. Zinga D, Phillips SD, Born L Postpartum depression: we know the risks, can it be prevented? Rev Bras Psiquiatr. 2005;27(Suppl 2):S56-64.
16. Bellantuono C, Migliarese G, Imperadore G. Pharmacologic therapy of depression during pregnancy. Recenti Prog Med. 2006;97(2):94-107.
17. Lisboa SF, Oliveira PE, Costa LC, Venâncio EJ, Moreira EG. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology. 2007;80(1):49-56.
18. van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Monoamines and abnormal behaviour. A multi-aminergic perspective. Br J Psychiatry. 1990;157:723-34. (Pubitemid 20360970)
19. Potter WZ, Rudorfer MV, Manji H. The pharmacologic treatment of depression. N Engl J Med. 1991;325(9):633-42.
20. Bergstrom RF, Lemberger L, Farid NA, Wolen RL. Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Psychiatry Suppl. 1988;(3):47-50.
21. Bairy KL, Madhyastha S, Ashok KP, Bairy I, Malini S. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology. 2007;79(1):1-11. (Pubitemid 46034171)
22. Coyle IR, Singer G. The interactive effects of prenatal imipramine exposure and postnatal rearing conditions on behaviour and histology. Psychopharmacologia. 1975;44(3):253-6.
23. DeVane CL, Simpkins JW. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose. Drug Metab Dispos. 1985;13(4):438-42.
24. Pinto FH, Ribeiro RD, Belda Neto FM, do Prado Júnior JC. Comparative study of the behavior of infection in mice, through subcutaneous and intraperitoneal inoculation, using 2 strains of Trypanosoma cruzi. Rev Saude Publica. 1986;20(2):133-40.
25. Halbe HW. Tratado de ginecologia. 2a ed. São Paulo: Roca; 1993.
26. Cash TF, Brown MA. Attitudes about antidepressants: influence of information about weight-related side effects. Percept Mot Skills. 2000;90(2):453-6.
27. Sussman N, Ginsberg DL, Bikoff J. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. J Clin Psychiatry. 2001;62(4):256-60. (Pubitemid 32428764)
28. Altemus M, Glowa JR, Galliven E, Leong YM, Murphy DL. Effects of serotonergic agents on food-restriction-induced hyperactivity. Pharmacol Biochem Behav. 1996;53(1):123-31. (Pubitemid 126349968)
29. Speiser Z, Fine T, Litinetsky L, Eliash S, Blaugrund E, Cohen S. Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline. J Neural Transm. 2008;115(1):107-16.
30. Vartazarmian R, Malik S, Baker GB, Boksa P. Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring. Psychopharmacology (Berl). 2005;178(2-3):328-38. (Pubitemid 40379228)
31. Byrd RA, Markham JK. Developmental toxicology studies of fluoxetine hydrochloride administered orally to rats and rabbits. Fundam Appl Toxicol. 1994;22(4):511-8.
32. Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Clin Neuropharmacol. 2007;30(6):326-34. (Pubitemid 350307311)
33. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry. 2003;160(5):993-6.
34. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry. 2000;48(10):1032-4.
35. Rozenthal M, Laks J, Engelhardt E. Neuropsychological aspects of depression. Rev Psiquiatr Rio Gd Sul. 2004;26(2):204-12.
36. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004;113(2):368-75.
37. Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE, Oberlander TF. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry. 2006;163(6):1026-32. (Pubitemid 44464489)
38. Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med. 2007;161(1):22-9. (Pubitemid 46045459)
39. Morrison JL, Riggs KW, Rurak DW. Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev. 2005;17(6):641-50.
40. Cabrera-Vera TM, Garcia F, Pinto W, Battaglia G. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. J Pharmacol Exp Ther. 1997;280(1):138-45. (Pubitemid 27171397)
41. Acebes I, Echevarría E, Abecia LC, Barbero I, Maza JL, Casis L. Comparison of the effects of the administration of fluoxetine and sertraline on the immune markers of the mu opioid receptor in the rat brain. Rev Neurol. 2000;31(10):919-22.